Praxis Precision Medicines, Inc. - Common Stock — Cash Flow (NASDAQ:PRAX) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -52.62 M-124.55 M-185.04 M-111.14 M-131.76 M-249.07 M -282.21 M Cash from investing activities 0-140.52 M96.89 M38.95 M-248.49 M-311.15 M -604.36 M Cash from financing activities 304.42 M107.59 M10.46 M91.87 M514.32 M702.17 M 1.26 B Free cash flow -52.62 M-124.55 M-185.04 M-111.14 M-131.76 M-249.12 M -282.33 M

News

Praxis Precision Medicines, Inc. (PRAX) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript

Praxis Precision Medicines, Inc. (PRAX) Q1 2026 Earnings Call Transcript

Why Praxis, A Top 1% Biotech, Just Surged Into A Bullish Breakout

3 Best Stocks to Buy Today, 4/7/2026, According to Top Analysts - TipRanks.com

Praxis: Strong Buy As Relutrigine Submission Accepted Plus Expansion Potential (PRAX)

BTIG reiterates Buy on Praxis Precision Medicines stock at $843

Xenon Smashes Its Previous Record High On 'Unprecedented' Results. Is A Buyout Next?

Praxis Precision Medicines, Inc. (PRAX) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Wolfe Research initiates Praxis stock with outperform rating

Praxis Precision Medicines stock reaches 52-week high at 337.01 USD

Praxis Precision Medicine Analysts Raise Their Forecasts After Q4 Results - Praxis Precision Medicine (NASDAQ:PRAX)

Truist reiterates Praxis Precision Medicines stock rating on pricing potential